Welcome to Journal of Hepatocellular Carcinoma
Ahmed O Kaseb Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Hepatocellular carcinoma (HCC) develops as a consequence of underlying chronic liver disease, most commonly cirrhosis. Therefore, HCC management draws on the ex...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-01-01
|
Series: | Journal of Hepatocellular Carcinoma |
Subjects: | |
Online Access: | https://www.dovepress.com/welcome-to-journal-of-hepatocellular-carcinoma-peer-reviewed-article-JHC |
id |
doaj-6188b183c6ea4d7690d5e9898d61abc5 |
---|---|
record_format |
Article |
spelling |
doaj-6188b183c6ea4d7690d5e9898d61abc52020-11-25T00:42:37ZengDove Medical PressJournal of Hepatocellular Carcinoma2253-59692015-01-012015Issue 11219914Welcome to Journal of Hepatocellular CarcinomaKaseb AOAhmed O Kaseb Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Hepatocellular carcinoma (HCC) develops as a consequence of underlying chronic liver disease, most commonly cirrhosis. Therefore, HCC management draws on the expertise of a wide range of medical specialists. Currently, novel therapeutic modalities for HCC are investigated within the framework of a multidisciplinary approach. Therefore, there is a critical need for a dedicated journal for HCC with special emphasis on understanding pathogenesis, emerging diagnosis and treatment approaches, and translational research strategies.The new journal Journal of Hepatocellular Carcinoma strives to be the essential clinical guide for medical and surgical oncologists, hepatologists, interventional radiologists, and all physicians and researchers involved in the care of patients with HCC. Our journal is committed to building an intercontinental community of researchers and clinicians to encourage establishment of collaborations and development of improved strategies to advance the field and help our patients from a global prospective. HCC is a very heterogeneous disease with multiple risk factors and noted differences in natural history and treatment outcomes based on demographics, risk factors, and even geographic locations, as evident by the noted difference in the magnitude of effects and rate of adverse events based on recent clinical trials conducted on different continents using the same systemic or local therapy modality.1 Therefore, one of the ultimate goals of the journal is to advance our understanding of the biology and natural history of HCC given the differential outcome based on these variables.https://www.dovepress.com/welcome-to-journal-of-hepatocellular-carcinoma-peer-reviewed-article-JHCjournalhepatocellular carcinoma |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Kaseb AO |
spellingShingle |
Kaseb AO Welcome to Journal of Hepatocellular Carcinoma Journal of Hepatocellular Carcinoma journal hepatocellular carcinoma |
author_facet |
Kaseb AO |
author_sort |
Kaseb AO |
title |
Welcome to Journal of Hepatocellular Carcinoma |
title_short |
Welcome to Journal of Hepatocellular Carcinoma |
title_full |
Welcome to Journal of Hepatocellular Carcinoma |
title_fullStr |
Welcome to Journal of Hepatocellular Carcinoma |
title_full_unstemmed |
Welcome to Journal of Hepatocellular Carcinoma |
title_sort |
welcome to journal of hepatocellular carcinoma |
publisher |
Dove Medical Press |
series |
Journal of Hepatocellular Carcinoma |
issn |
2253-5969 |
publishDate |
2015-01-01 |
description |
Ahmed O Kaseb Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA Hepatocellular carcinoma (HCC) develops as a consequence of underlying chronic liver disease, most commonly cirrhosis. Therefore, HCC management draws on the expertise of a wide range of medical specialists. Currently, novel therapeutic modalities for HCC are investigated within the framework of a multidisciplinary approach. Therefore, there is a critical need for a dedicated journal for HCC with special emphasis on understanding pathogenesis, emerging diagnosis and treatment approaches, and translational research strategies.The new journal Journal of Hepatocellular Carcinoma strives to be the essential clinical guide for medical and surgical oncologists, hepatologists, interventional radiologists, and all physicians and researchers involved in the care of patients with HCC. Our journal is committed to building an intercontinental community of researchers and clinicians to encourage establishment of collaborations and development of improved strategies to advance the field and help our patients from a global prospective. HCC is a very heterogeneous disease with multiple risk factors and noted differences in natural history and treatment outcomes based on demographics, risk factors, and even geographic locations, as evident by the noted difference in the magnitude of effects and rate of adverse events based on recent clinical trials conducted on different continents using the same systemic or local therapy modality.1 Therefore, one of the ultimate goals of the journal is to advance our understanding of the biology and natural history of HCC given the differential outcome based on these variables. |
topic |
journal hepatocellular carcinoma |
url |
https://www.dovepress.com/welcome-to-journal-of-hepatocellular-carcinoma-peer-reviewed-article-JHC |
work_keys_str_mv |
AT kasebao welcometojournalofhepatocellularcarcinoma |
_version_ |
1725281407929942016 |